Prognica Labs Receives Prestigious Recognition as Future100 Company, Celebrating Innovation in Health Technology

Dubai, UAE, 12 Feb, 2024: Prognica Labs, an award-winning Health Tech firm based in Dubai, proudly announces its prestigious recognition as one of the Future100 companies, a distinctive honor celebrating pioneering entities driving innovation and competitiveness in the UAE’s burgeoning economic landscape. The Future100 initiative applauds the top 100 emerging companies propelling the future economic sectors of the UAE, showcasing their contributions to the country’s forward-looking private sector. The unveiling of the 2023 Future 100 list occurred at a gathering in Dubai’s Museum of the Future. H.E. Abdullah bin Touq Al Marri, UAE Minister of Economy, and H.E. Ohood bint Khalfan Al Roumi, UAE Minister of State for Government Development and The Future, were present at the event, along with top officials from the awarded companies.

"We congratulate the 100 companies that successfully made it to the final stage of the initiative's first edition to become the best 100 companies of the future, possessing pioneering capabilities for growth and healthy competition," Al Marri stated. "We believe this is a turning point that will enable these companies to achieve more sustainable commercial success and access to regional and global markets."

A trailblazer in the health-tech sphere, Prognica Labs has earned numerous accolades for its steadfast dedication to research, development, marketing, and sales of cutting-edge medical software products. At the core of Prognica’s offerings lies AI-based technology, leveraging evidence-based algorithms, machine learning, and computer vision to deliver real-time clinical insights across all healthcare touchpoints. Central to Prognica’s mission is a commitment to revolutionizing healthcare, particularly in the domain of breast cancer screening and diagnostics. The company’s vision focuses on enhancing accuracy, affordability, and accessibility, propelling early detection and intervention strategies.

Prognica Labs’ pioneering approach, centered on AI-driven solutions for real-time clinical insights, cements its role as a frontrunner in reshaping the healthcare industry.

"Khalid Shaikh, Founder & CEO of Prognica Labs expressed gratitude, stating, "Recognition as a Future100 company reinforces our commitment to harnessing technology's power for the advancement of healthcare, especially in improving breast cancer screening and diagnostics."